29 Apr 2010 Novavax's Seasonal Influenza VLP Vaccine Candidate Shows Positive Results in a Phase II Clinical Trial in Older Adults
28 Apr 2010 Second successful Phase I/II Clinical Trial for BiondVax's Universal Flu Vaccine
28 Apr 2010 ChronTech Pharma AB: ChronSeal study completed and continuing positive results in the follow-up of the ChronVac-C-study
28 Apr 2010 Pepscan Signs Partnering Agreement With Immunovo for its Therapeutic Vaccine Portfolio
28 Apr 2010 Data From LigoCyte's Clinical Studies of Norovirus VLP Vaccine Presented at 13th Annual Conference on Vaccine Research
27 Apr 2010 Generex Announces Updated Phase I Results From Novel Immunotherapeutic Vaccine Presented at the European Association of Urology Congress
27 Apr 2010 Dynavax Reports Positive Data on Universal Flu Vaccine Candidate
27 Apr 2010 Vical Reports Encouraging Updates From U.S. Military Malaria Vaccine Programs
27 Apr 2010 VaxInnate’s VAX125 Seasonal Flu Vaccine Shown Safe and Highly Immunogenic in Phase II Study of Elderly Subjects
26 Apr 2010 Pevion Announces Excellent Preclinical Results for PEV4 RSV Vaccine Candidate
23 Apr 2010 AFFiRiS AG: Alzheimer's Vaccine AD02 Already in Clinical Phase II
22 Apr 2010 Fraunhofer Centers in Newark, DE, and at Boston University Develop Plant-Based Vaccine Factory based on Proprietary Expression Technology of iBio, Inc.
22 Apr 2010 Vical Presents Encouraging Preliminary Data From Final 12-month Follow-up in TransVax(TM) CMV Vaccine Phase 2 Transplant Recipient Trial
22 Apr 2010 Immunovaccine Signs Research Agreement with Dana-Farber Cancer Institute
21 Apr 2010 Merck Obtains Exclusive Rights to Market and Distribute MassBiologics' Tetanus-Diphtheria (Td) Vaccine in the U.S.
19 Apr 2010 NanoBio Launches Development Program for a Therapeutic Intranasal Vaccine for the Treatment of Hepatitis B
19 Apr 2010 Stallergenes: Positive Results for Oralair(R) Phase III Trial in the USA
19 Apr 2010 Systemic and Antigen-Specific Immune Responses in Patients Treated With Cancer Vaccine BPX-101 Correlate With Clinical Response
19 Apr 2010 GlobeImmune's Hepatitis C Product Candidate Improves End of Treatment Response in All IL-28 B Genotypes, With the Greatest Effect in the Hardest-to-Treat Patients
19 Apr 2010 ABRAXANE in Combination with Gemcitabine Increases Survival in First-Line Treatment of Advanced Pancreatic Cancer in Phase I/II Study
19 Apr 2010 New Preclinical Breast Cancer Study Shows Peregrine's PS-Targeting Antibodies Can Reverse Tumor-Induced Immune Suppression
15 Apr 2010 Advaxis Initiates Phase II Cervical Dysplasia (CIN) Trial
15 Apr 2010 GlobeImmune GI-5005 HCV Product Candidate Improves Sustained Virologic Response by 10 Percent, Demonstrating Potential to Be First Therapeutic Vaccine for HCV
15 Apr 2010 Dynavax's Chronic Kidney Disease Study Confirms HEPLISAV's Enhanced Seroprotection Against HBV Infection
15 Apr 2010 Genocea Biosciences Enters Into Cooperative Research and Development Agreement with U.S. Military to Develop Malaria Vaccine

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up